Dietary trial in prostate cancer: Early experience and implications for clinical trial design. Read more about Dietary trial in prostate cancer: Early experience and implications for clinical trial design.
Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials. Read more about Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials.
Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Read more about Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database.
Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up. Read more about Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.
Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer. Read more about Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.
Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy. Read more about Additional treatments and reimbursement rates associated with prostate cancer treatment for patients undergoing radical prostatectomy, interstitial brachytherapy, and external beam radiotherapy.
Fifteen-year minimum follow-up of a prostate brachytherapy series: comparing the past with the present. Read more about Fifteen-year minimum follow-up of a prostate brachytherapy series: comparing the past with the present.
Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database. Read more about Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database.
Hematospermia as the presenting symptom of metastatic malignant melanoma of unknown primary origin. Read more about Hematospermia as the presenting symptom of metastatic malignant melanoma of unknown primary origin.
Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Read more about Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia.
